PT934057E - Formulacoes medicinais de aerossois com formoterol - Google Patents

Formulacoes medicinais de aerossois com formoterol

Info

Publication number
PT934057E
PT934057E PT97929756T PT97929756T PT934057E PT 934057 E PT934057 E PT 934057E PT 97929756 T PT97929756 T PT 97929756T PT 97929756 T PT97929756 T PT 97929756T PT 934057 E PT934057 E PT 934057E
Authority
PT
Portugal
Prior art keywords
formoterol
aerosols
medical formulations
formulations
medical
Prior art date
Application number
PT97929756T
Other languages
English (en)
Portuguese (pt)
Inventor
Philip A Jinks
Martin J Oliver
Simon G Paling
Sukhbinder K Jaiswal
Original Assignee
Minnesota Mining & Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10795182&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT934057(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Minnesota Mining & Mfg filed Critical Minnesota Mining & Mfg
Publication of PT934057E publication Critical patent/PT934057E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT97929756T 1996-06-11 1997-06-02 Formulacoes medicinais de aerossois com formoterol PT934057E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9612297.3A GB9612297D0 (en) 1996-06-11 1996-06-11 Medicinal aerosol formulations

Publications (1)

Publication Number Publication Date
PT934057E true PT934057E (pt) 2004-12-31

Family

ID=10795182

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97929756T PT934057E (pt) 1996-06-11 1997-06-02 Formulacoes medicinais de aerossois com formoterol

Country Status (16)

Country Link
EP (2) EP0934057B1 (OSRAM)
JP (1) JP5000793B2 (OSRAM)
AR (1) AR009231A1 (OSRAM)
AT (1) ATE275940T1 (OSRAM)
AU (1) AU726382B2 (OSRAM)
CA (1) CA2257841C (OSRAM)
DE (1) DE69730723T2 (OSRAM)
DK (1) DK0934057T3 (OSRAM)
ES (1) ES2229366T3 (OSRAM)
GB (1) GB9612297D0 (OSRAM)
ID (1) ID19520A (OSRAM)
NO (1) NO320403B1 (OSRAM)
NZ (1) NZ333202A (OSRAM)
PT (1) PT934057E (OSRAM)
WO (1) WO1997047286A1 (OSRAM)
ZA (1) ZA974546B (OSRAM)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054488A (en) * 1996-06-11 2000-04-25 3M Innovative Properties Company Medicinal aerosol formulations of formoterol
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US6423298B2 (en) * 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
US6451285B2 (en) * 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
ID29605A (id) * 1998-10-17 2001-09-06 Boehringer Ingelheim Pharma Konsentrat bahan aktif dengan formoterol, yang sesuai untuk penyimpanan
DE19847969A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähig flüssige Formulierung mit Formoterol
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
US6290930B1 (en) 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
HRP20021025B1 (hr) * 2000-05-22 2013-11-22 Chiesi Farmaceutici S.P.A. Formulacije stabilnih farmaceutskih otopina za inhalatore s odmjerenom dozom pod tlakom
SE0004750D0 (sv) 2000-12-19 2000-12-19 Astrazeneca Ab Novel formulation
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
ES2222294T3 (es) 2001-07-02 2005-02-01 Chiesi Farmaceutici S.P.A. Formulacion optimizada de tobramicina para administracion en forma de aerosol.
TWI324934B (en) * 2001-08-28 2010-05-21 Schering Corp Pharmaceutical compositions for the treatment of asthma
GB0207899D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and cielesonide aerosol formulations
GB0207906D0 (en) 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
EP1878664B1 (en) 2002-08-27 2011-03-30 Schering Corporation Process for producing metered dose inhaler formulations
EP1635845A1 (en) * 2003-06-13 2006-03-22 ALTANA Pharma AG Formoterol and ciclesonide combination
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
EP1925293A3 (en) * 2003-10-20 2010-01-13 Schering Corporation Pharmaceutical aerosol compositions
AU2004285447A1 (en) * 2003-10-20 2005-05-12 Schering Corporation Pharmaceutical compositions
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
ES2398480T3 (es) * 2006-10-17 2013-03-19 Lithera, Inc. Procedimientos, composiciones, y formulaciones para el tratamiento de la enfermedad ocular tiroidea
PT3111927T (pt) * 2009-05-29 2020-03-03 Pearl Therapeutics Inc Composições para administração respiratória de agentes ativos e métodos e sistemas associados
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
KR101778814B1 (ko) * 2009-10-02 2017-09-15 키에시 파르마슈티시 엣스. 피. 에이. 포모테롤 및 베클로메타손 디프로피오네이트의 약학적 에어로졸 제제
TR201902687T4 (tr) 2013-03-15 2019-03-21 Pearl Therapeutics Inc İri parçacıklı kristal malzemelerin koşullandırılması için yöntemler ve sistemler.

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0460064A4 (en) * 1989-02-23 1992-04-01 Rorer International (Holdings) Inc. Therapeutic aerosol formulations
IL97065A (en) * 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
EP1092430B1 (en) * 1991-06-10 2003-08-06 Schering Corporation Non-chlorofluorocarbon aerosol formulations
EP0587790B2 (en) * 1991-06-10 2000-03-08 Schering Corporation Non-chlorofluorocarbon aerosol formulations
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
ATE128350T1 (de) * 1991-12-12 1995-10-15 Glaxo Group Ltd Pharmazeutische aerosolformulierung.
ES2216800T3 (es) * 1991-12-18 2004-11-01 Minnesota Mining And Manufacturing Company Formulaciones de aerosol en suspension.
GB9207400D0 (en) * 1992-04-02 1992-05-13 Smithkline Beecham Plc Novel use
US5354934A (en) * 1993-02-04 1994-10-11 Amgen Inc. Pulmonary administration of erythropoietin
GB9425160D0 (en) * 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
GB9426252D0 (en) * 1994-12-24 1995-02-22 Glaxo Group Ltd Pharmaceutical composition

Also Published As

Publication number Publication date
CA2257841C (en) 2008-05-20
AR009231A1 (es) 2000-04-12
ID19520A (id) 1998-07-16
WO1997047286A1 (en) 1997-12-18
EP1400239A1 (en) 2004-03-24
JP5000793B2 (ja) 2012-08-15
EP0934057B1 (en) 2004-09-15
DE69730723T2 (de) 2005-10-06
CA2257841A1 (en) 1997-12-18
NO985720D0 (no) 1998-12-07
NZ333202A (en) 2000-06-23
NO985720L (no) 1999-02-11
NO320403B1 (no) 2005-11-28
ATE275940T1 (de) 2004-10-15
DE69730723D1 (de) 2004-10-21
EP0934057A1 (en) 1999-08-11
DK0934057T3 (da) 2005-01-24
AU3373997A (en) 1998-01-07
AU726382B2 (en) 2000-11-02
ZA974546B (en) 1998-11-23
JP2000513340A (ja) 2000-10-10
GB9612297D0 (en) 1996-08-14
ES2229366T3 (es) 2005-04-16

Similar Documents

Publication Publication Date Title
PT934057E (pt) Formulacoes medicinais de aerossois com formoterol
PT101722A (pt) Formulacoes de analogo de insuluna
DE69519975D1 (de) Medizinisches Beobachtungsinstrument
BR9408491A (pt) Utilização de carbono descartado
ATE236617T1 (de) Aerosol-arzneiformulierungen
DE69525602D1 (de) Chirurgisches Instrument
DE69532486D1 (de) Chirurgisches Instrument
DE59508901D1 (de) Chirurgisches instrument
PT917463E (pt) Formulacoes unidades multiplas de tramadol
DK0850059T3 (da) Farmaceutiske formuleringer indeholdende darifenacin
PT769965E (pt) Formulacoes aquosas de risperidona
ATE320246T1 (de) Medizinische aerosolformulierungen enthaltend budesonide
IT1292206B1 (it) Strumento medico
DE59307505D1 (de) Medizinisches Instrument
DE59405342D1 (de) Zerlegbares medizinisches Instrument
FI953887A7 (fi) Kefaklorin farmaseuttisia formulaatioita
ID18832A (id) Komposisi insektisida
ITMI941169A0 (it) Formulazioni farmaceutiche
FI963263A0 (fi) Bromelaiinin lääkinnällinen käyttö
ID23774A (id) Komposisi insektisida
DE69728832T2 (de) Optometrisches Instrument
FR2755861B1 (fr) Potence medicale individuelle portee
KR980004324U (ko) 의료용 가습기
SE9404467D0 (sv) Drug formulations
KR960018574U (ko) 모니터의 노브구조